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An unusual anti-H lectin inhibited
by milk from individuals with the
Bombay phenotype
S.R. JOSHI, K.VASANTHA,AND J.S. ROBB
There are several lectins with anti-H specificity but few of them
serve as useful reagents. An anti-H lectin, extracted from the seeds
of the plant Momordica dioica Roxb. ex willd., was tested for its
hemagglutination and inhibition properties, using standard
serologic methods and panel RBCs, serum, saliva, milk, and oligo-
saccharides purified from milk. The extract displayed strongest
agglutination with group O RBCs and was weakest with group A1B
RBCs in a spectrum of O>A2>B>A2B>A1>A1B; the extract failed to
react with the RBCs from 25 individuals with the Bombay (Oh)
phenotype and was inhibited by H secretor saliva, hence it was
characterized as anti-H. However, its inhibition by milk samples
from five mothers with the Bombay phenotype called into question
its specificity as anti-H. The lectin reacted as strongly with group O
ii (adult) RBCs as with normal OI RBCs, ruling out its specificity as
anti-HI. Hemagglutination inhibition was observed with 2´-
fucosyllactose (Type 2 H) and lacto-N-fucopentose-I (Type 1 H),
suggesting that the binding of the lectin had preference for H
structures. However, inhibition by N-acetyllactosamine, lacto-N-
tetraose, and lacto-N-neotetraose suggested that the lectin also
recognized unsubstituted terminal beta-linked galactose units. The
hemagglutinin property in the present lectin showed an unusual
anti-H specificity. The lectin was inhibited by milk from Bombay
phenotype individuals and certain milk oligosaccharides not
specific for the H antigen. Immunohematology 2005;21:1–4.
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Anti-H of Ulex europaeus is a lectin widely used in
identifying Bombay and para-Bombay phenotypes as
well as in determining the secretor status of an
individual. Anti-H-like lectins from other plants, i.e.,
Cerastium tomentosum, Cytisus sessilifolius, Lotus
tetragonolobus, Laburnum alpinum, etc., do react to
a variable extent with Bombay phenotype RBCs.
However, they have anti-HI specificities and are not
useful in determining secretor status.1,2 We describe an
anti-H lectin from the seeds of Momordica dioica
Roxb. ex willd. The plant, popularly known in the
region as Kantola, is a perennial dioecious climber,
grown abundantly throughout India during the rainy
season (July–September).3 This lectin, as well as Ulex
europaeus anti-H,can be used to confirm that RBCs are
of the Oh phenotype. Although the lectin was inhibited
by saliva from H secretors and not by saliva from H
nonsecretors, it was inhibited by milk samples from
some individuals irrespective of their secretor status.




The dry seeds were pulverized at 10% w/v in
normal saline. The homogenized mixture was left at
room temperature for 4 hours followed by centrifu-
gation at 4500 rpm for 5 minutes. The opalescent
extract was aspirated off the fatty layer settled at the
top. The extract was treated with ether to remove lipid
remnants. The pH of the extract was adjusted to 7
using 1N NaOH.
Standard serologic procedures were followed
throughout4 and an inhouse panel of RBCs was used to
characterize the serologic specificity. Equal volumes of
lectin and a 2% suspension of Group O RBCs were
mixed and incubated at room temperature for 30
minutes followed by centrifugation at 1000 rpm for 1
minute and macroscopic reading of the results.
Negative reactions were confirmed microscopically.
Agglutination reactions were graded and scored as
reported by Marsh.5
The following fluids and substances were used in
the study: boiled saliva from persons of predetermined
secretor status and Lewis phenotype, human milk from
women who had recently delivered, and purified milk
oligosaccharides.
For hemagglutination-inhibition studies, the saliva
and milk samples were serially diluted in saline and 50
µl of each of the serially diluted samples was mixed
with 50 µl of a 1:8 dilution of lectin. The test was
incubated at room temperature for 30 minutes, then 50
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µl of the 2% RBC suspension was added. The test was
further incubated at room temperature for 30 minutes
and results were read after centrifugation of the test at
1000 rpm for 1 minute. The inhibition intensity was
considered to be the dilutions of saliva or milk in
which no hemagglutination was observed. For the
study using purified milk oligosaccharides (which were
kindly provided by Dr.W.Watkins), the serial dilutions
(in saline) of the 0.1 M sugar solutions were mixed
with an equal volume of the diluted lectin. As a
procedural control, saline was substituted for the fluid
or other substance and tested as described above.
To assess whether the inhibition of the anti-H by
milk samples was merely due to their high osmotic
molarity or pH, milk samples (frozen-stored) from two
different Bombay phenotype mothers were dialyzed
against 0.1 M PBS, pH 7, at 4°C for 24 hours and used
for hemagglutination inhibition of the present anti-H
lectin of Momordica dioica.
Avidity of the serologic reaction was measured as
the time (expressed in seconds) taken by the lectin to
form visible agglutination when added to a mixture of
equal volumes of saline or citrate and RBCs on a slide.
Results
Hemagglutination studies
The raw extract showed instant gross hemolysis of
the saline-suspended RBCs up to a dilution of 1:4, after
which it agglutinated RBCs up to 1:64. The hemolytic
property of the lectin, without affecting its
agglutinating activity, was greatly reduced by the
addition of human serum or bovine serum albumin to
the extract. A greater strength of agglutination was
observed if the RBCs were suspended in 3.8% sodium
citrate solution (avidity 5 seconds, titer 64, score 45) as
compared to RBCs suspended in normal saline (avidity
12 seconds, titer 32, score 30). (The results are not
tabulated.)  The lectin was standardized for its
optimum reactivity by mixing the raw extract, 3.8%
solution of sodium citrate, and 22% bovine serum
albumin in a ratio of 3:2:1, respectively, and was used
throughout the study.
The extract reacted with all group A,B, and O RBCs
tested but failed to react with the RBCs from the 25
Bombay phenotype donors, thereby determining that it
is specific for the H antigen. The reaction pattern
obtained with the RBCs from various ABO phenotypes
showed a minimum strength of agglutination with
group A1B RBCs and a maximum strength with group O
RBCs. RBCs of other ABO phenotypes reacted in
varying degrees of agglutination in the order of
O>A2>B>A2B>A1>A1B. The lectin did not agglutinate Oh
RBCs even if they were pretreated with papain or
sialidase. (The results are not tabulated.)  The lectin
agglutinated group O RBCs that had different Ii
phenotypes, e.g., adult OI, adult Oii, and cord RBCs, in
almost equal titer strength, though the score values
obtained for the cord blood were slightly lower than
those for the other RBCs (Table 1).
Hemagglutination-inhibition studies using saliva
and human milk
Hemagglutination-inhibition studies were carried
out using 30 saliva samples from different individuals
with various secretor statuses and Lewis blood group
phenotypes. Of these,20 were from individuals with H
substance and were of the Le(a–b+) or Le(a–b–)
phenotype while the remaining 10, including five from
Oh phenotype individuals, were from individuals who
lacked H substance and were of the Le(a+b–)
phenotype. The saliva samples with H substance
inhibited the agglutination of the RBCs by the lectin,
whereas those that lacked the substance did not.
Interestingly, 11 samples of human milk, including five
samples from the Bombay phenotype mothers,
exhibited hemagglutination inhibition. (A typical
inhibition pattern is shown in Table 2, Nos. 12 and 13.)
It is noteworthy that the lectin was inhibited by milk
samples from the Bombay Oh phenotype individuals,
even though it did not agglutinate Oh RBCs. Dialyzed
milk samples showed the same hemagglutination
inhibition as was seen with the nondialyzed milk
samples. (The results are not tabulated.)  In a separate
control test, Ulex europaeus was not inhibited by milk
samples from two of the mothers with the Bombay
phenotype. (The results are not tabulated.)
Hemagglutination-inhibition studies using purified
milk oligosaccharides 
The anti-H lectin showed maximum inhibition by
2´-fucosyllactose (sugar 5 in the list) and lacto-N-
fucopentaose I (sugar 7) (Table 2). It was also inhibited
Table 1. Titer/score of anti-H lectin of Momordica dioica Roxb. ex willd.
versus group O RBCs of different Ii phenotypes 
RBCs
OI O, ii* O, cord
Results (N=10) (N=3) (N=3)
Titer 32 (N=8), 16 (N=2) 32, 16, 32 32, 16, 32
Score 63 (average) 54 46
*Frozen preserved
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by N-acetyllactosamine (sugar 1), lacto-N-tetraose
(sugar 2), and lacto-N-neotetraose (sugar 3), though to
a lesser degree. Lacto-difucotetraose (sugar 4), 3-
fucosyllactose (sugar 6), and lacto-N-fucopentaose II
(sugar 8) did show inhibition, but to a very limited
extent. However, lacto-N-fucopentaose III (sugar 9) and
lacto-difucohexaose I and II (sugars 10 and 11) did not
inhibit the hemagglutinating property of the lectin.
Discussion
Anti-H occurs in nature as an alloantibody in
Bombay and para-Bombay (nonsecretor) individuals, as
an autoantibody in persons irrespective of their ABO
blood group, and as a lectin in the seeds of certain
plants.6 Anti-H of human origin is usually contaminated
with coexisting anti-A, anti-B, or both in the serum,
thereby limiting its usefulness as a monospecific
reagent. The anti-H lectin prepared from Ulex
europaeus is a useful reagent but those described from
some other plants are not.6
The lectin from Momordica dioica Roxb. ex willd.
exhibited some interesting features. The agglutinating
property was obscured by a pan-hemolysin present in
the raw extract that required neutralization by bovine
serum albumin or human serum. The neutralized lectin
agglutinated RBCs of all ABO groups except those from
25 Bombay phenotype individuals. The lectin did not
react with Oh RBCs even after pretreatment with
enzymes, suggesting that it is highly specific for the H
antigen. The agglutination pattern with various ABO
blood group phenotypes further suggested its anti-H
specificity and its serologic reactivity were akin to the
anti-H lectin from Ulex europaeus. Hemagglutination
inhibition by H secretor saliva but not by nonsecretor
saliva appeared to confirm H specificity. However, the
lectin was totally inhibited by all samples of human
milk tested, including 5 of 5 samples from Bombay
phenotype individuals. Inhibitory activities retained
after dialysis of the milk from Bombay phenotype
individuals suggests that the inhibition was not due to
the osmolarity or pH. It also suggests the presence of
a high–molecular weight fucosylated glycoprotein
apart from the H-specific glycoprotein that shows this
hemagglutination inhibition. Bombay phenotype
individuals genetically lack H. Therefore, hemaggluti-
nation inhibition of the lectin by milk from mothers
with the Bombay phenotype modifies its specificity as
pure anti-H. Additionally, Ulex europaeus was not
inhibited by milk from the Bombay mothers, thus
showing distinct differences from the lectin of
Momordica dioica Roxb.ex willd. Because milk is rich
in soluble I antigen,7 and as the lectin was neutralized
by various milk samples, its specificity was indicative of
possible anti-I or anti-HI. However, both of these
possibilities were ruled out because the lectin
agglutinated group O ii RBCs and did not agglutinate
Bombay I-positive RBCs. Inhibition of fucose-binding
lectins by milk samples from mothers who are
nonsecretors was also observed by N. Gilboa-Garber,
Ph.D. (written communication, July 2001).
Bird and Wingham1 described the lectin in
Jerusalem sage (Phlomis fruticosa) with anti-A,B
specificity wherein anti-B activity was neutralized by N-
acetyl-D-galactosamine, the terminal sugar specific for
blood group A antigen. They explained that the A and
B antigen binding sites were situated on a single lectin
molecule and both binding sites were inhibited by
either of the specific sugars. It is likely that the present
lectin also has dual binding sites, one for the terminal
sugar specific for H antigen and the other for the
terminal sugar of a different antigen, and that both
binding sites were inhibited by sugars for either of the
specificities.
The best inhibition by 2´-fucosyllactose (Type 2 H)
and lacto-N-fucopentaose I (Type 1 H) suggests that the
binding site of the lectin has preference to the H
structure. However, inhibition by N-acetyllactosamine,
lacto-N-tetraose, and lacto-N-neotetraose suggests that
the lectin also recognizes unsubstituted terminal beta-
linked galactose units. Inhibition of this lectin by milk
samples from Bombay phenotype mothers may also be
Table 2. Hemagglutination-inhibition titer of various milk/
oligosaccharide samples obtained using lectin Momordica
dioica Roxb. ex willd.
Inhibition
Sugar No. Milk/oligosaccharide Specificity titer
1 N-acetyllactosamine – 128
2 Lacto-N-tetraose – 128
3 Lacto-N-neotetraose – 64
4 Lacto-difucotetraose – 8
5 2´-fucosyllactose Ht2 512
6 3-fucosyllactose – 4
7 Lacto-N-fucopentaose-I Ht1 512
8 Lacto-N-fucopentaose-II Lea 8
9 Lacto-N-fucopentaose-III Lex 0
10 Lacto-N-difucohexaose-I Leb 0
11 Lacto-N-difucohexaose-II Lea 0
12 Milk, mother, group O – 128
13 Milk, mother, Oh – 32
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attributed to such sugars present in the milk.8
Interestingly, the presence of fucose on the subterminal
sugar (as in lacto-difucotetraose, 3-fucosyllactose,
lacto-N-fucopentaose II or III, or lacto-difucohexaose 
I or II) reduces the ability of the lectin to recognize the
terminal galactose or the galactose when alpha-2-
linked to fucose.
Conclusion
The lectin in the Momordica dioica agglutinated
RBCs from persons other than those of the Bombay
phenotype. Its reactivity was inhibited by H secretor
saliva and purified milk oligosaccharides specific for H,
suggesting its specificity as anti-H. Its inhibition by
milk and certain milk oligosaccharides not specific for
H modified its specificity as pure anti-H. Its strong
reaction with O ii RBCs and its failure to react with Oh,
I-positive RBCs ruled out anti-I specificity. Thus, the
lectin has a unique specificity in comparison with
other lectins with anti-H specificity.
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